| 000 | 01725 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517183358.0 | ||
| 264 | 0 | _c20180711 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1872-9096 | ||
| 024 | 7 |
_a10.1016/j.antiviral.2017.10.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarathe, Bindumadhav M | |
| 245 | 0 | 0 |
_aA pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment. _h[electronic resource] |
| 260 |
_bAntiviral research _cDec 2017 |
||
| 300 |
_a20-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 |
_aInfluenza B virus _xclassification |
| 650 | 0 | 4 |
_aLung _ximmunology |
| 650 | 0 | 4 | _aMadin Darby Canine Kidney Cells |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNeuraminidase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOrthomyxoviridae Infections _xdrug therapy |
| 650 | 0 | 4 |
_aOseltamivir _xpharmacology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aViral Load _xdrug effects |
| 650 | 0 | 4 |
_aVirulence _xdrug effects |
| 650 | 0 | 4 |
_aVirus Replication _xdrug effects |
| 700 | 1 | _aMostafa, Heba H | |
| 700 | 1 | _aVogel, Peter | |
| 700 | 1 | _aPascua, Philippe Noriel Q | |
| 700 | 1 | _aJones, Jeremy C | |
| 700 | 1 | _aRussell, Charles J | |
| 700 | 1 | _aWebby, Richard J | |
| 700 | 1 | _aGovorkova, Elena A | |
| 773 | 0 |
_tAntiviral research _gvol. 148 _gp. 20-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.antiviral.2017.10.021 _zAvailable from publisher's website |
| 999 |
_c27751987 _d27751987 |
||